PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40632497,Deciphering the MHC immunopeptidome of human cancers with Ligand.MHC atlas.,2025,Suo S,"Guangzhou National Laboratory, Guangzhou 510005, China.",N/A
40631977,Going With the Flow: Circulating Tumor-Reactive Lymphocytes Stream Into Cancer Therapy.,2025,"Alvarez-Rodríguez R, Vuchkovska A, Wang Z, Chartier C, Hege K, Kalos M","cTRL Therapeutics, Chicago, Illinois, United States., cTRL Therapeutics, Chicago, Illinois, United States., cTRL Therapeutics, Chicago, Illinois, United States., cTRL Therapeutics, Chicago, Illinois, United States., cTRL Therapeutics, Chicago, Illinois, United States., Next Pillar Consulting, wayne, PA, United States.",N/A
40631774,First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors.,2025,"Hoyle PE, Dong Z, Cheng L, Chen X, Janik JE, Bourayou N","Incyte Corporation, Wilmington, DE 19803, United States., Incyte Corporation, Wilmington, DE 19803, United States., Incyte Corporation, Wilmington, DE 19803, United States., Incyte Corporation, Wilmington, DE 19803, United States., Incyte Corporation, Wilmington, DE 19803, United States., Incyte Biosciences International Sàrl, 1110 Morges, Switzerland.",N/A
40631773,First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors.,2025,"Hoyle PE, Dong Z, Cheng L, Gong X, Janik JE, Bourayou N","Incyte Corporation, Wilmington, DE 19803, USA., Incyte Corporation, Wilmington, DE 19803, USA., Incyte Corporation, Wilmington, DE 19803, USA., Incyte Corporation, Wilmington, DE 19803, USA., Incyte Corporation, Wilmington, DE 19803, USA., Incyte Biosciences International Sàrl, 1110 Morges, Switzerland.",N/A
40631030,"Physician specialty shapes hypothetical self-treatment choices for locally advanced non-small cell lung cancer: Is the ""best"" option subjective?",2025,"Faivre-Finn C, Popat S","Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom., Thoracic Oncology, The Royal Marsden, London, United Kingdom.",N/A
